Page last updated: 2024-08-23

isofenphos and Atrial Fibrillation

isofenphos has been researched along with Atrial Fibrillation in 2 studies

*Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation. [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Chiu, YD; Fynn, S; Holcombe, HM; Mills, C; Nashef, SAM; Sharples, LD1
GarcĂ­a-Villarreal, OA1

Trials

1 trial(s) available for isofenphos and Atrial Fibrillation

ArticleYear
Five-year results of Amaze: a randomized controlled trial of adjunct surgery for atrial fibrillation.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2022, 10-04, Volume: 62, Issue:5

    Topics: Atrial Fibrillation; Catheter Ablation; Humans; Quality of Life; Stroke; Treatment Outcome

2022

Other Studies

1 other study(ies) available for isofenphos and Atrial Fibrillation

ArticleYear
The full bi-atrial lesion pattern in the Cox-maze procedure: a concept rather than a technique.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2022, 12-02, Volume: 63, Issue:1

    Topics: Atrial Fibrillation; Heart Valve Diseases; Humans; Organothiophosphorus Compounds

2022